Question 1

What specific treatments will I receive if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer clinical trial (NCT06385080). Contact the study team or your healthcare provider for specific answers.

Question 2

How does amivantamab compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer clinical trial (NCT06385080). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the treatments in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer clinical trial (NCT06385080). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and tests during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer clinical trial (NCT06385080). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer clinical trial (NCT06385080). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my overall health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer clinical trial (NCT06385080). Contact the study team or your healthcare provider for specific answers.

What this study is about